|
|
Office Locations:
|
3000 Sand Hill Road
Building 1, Suite 260
Menlo Park, CA 94025
Phone: 650-233-0700
| |
|
|
|
|
Information Technology
Software & Internet
|
|
|
Nexus is a leading Indian Venture Capital fund with $320 million under management. The firm invests in early and early growth stage companies across sectors. With offices in India and Silicon Valley, Nexus mainly invests in companies that are wholly or substantially located in India. However, on a selective basis, the firm may invest in companies located outside India that are seeking a value added Indian investor to complement their local investor base. Nexus typically invests early in the life of the company and in many cases is the first institutional round of capital. The firm's investment size ranges from $500,000 to $10 million, and the partners typically limit their investments to 6-8 new investments a year. Nexus has a seed program to support high potential entrepreneurs with breakthrough ideas with investment of up to $500,000.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|
|
Name | |
| |
Title | |
|
Abhishek Sharma | |
| |
Investor | |
Anand Datta | |
| |
| |
Anup Gupta | |
| |
Managing Director | |
Jishnu Bhattacharjee | |
| |
Managing Director | |
K G Subramanian | |
| |
CFO | |
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
10/16/2024
|
Neuron7.ai
|
CA
|
$44,000,000
|
Series B
|
10/09/2024
|
TensorWave
|
NV
|
$43,000,000
|
SAFE
|
07/03/2024
|
Rocketlane
|
CA
|
$24,000,000
|
|
06/25/2024
|
Rocketlane
|
CA
|
$24,000,000
|
Series B
|
06/24/2024
|
Iambic Therapeutics
|
CA
|
$50,000,000
|
Series B Extension
|
05/07/2024
|
Daloopa
|
NY
|
$18,000,000
|
Series B
|
02/21/2024
|
Orkes
|
CA
|
$20,000,000
|
|
|
|
|
|
|